Published in JAMA on January 27, 1989
Methadone maintenance treatment in opiate dependence: a review. BMJ (1994) 7.37
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health (1996) 5.45
Sociometric risk networks and risk for HIV infection. Am J Public Health (1997) 3.29
HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health (1993) 3.05
HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health (2004) 2.96
Risk factors for syphilis: cocaine use and prostitution. Am J Public Health (1990) 2.65
Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am J Public Health (1992) 2.43
Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis (2010) 2.32
A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug users. J Appl Behav Anal (2007) 2.16
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep (1998) 1.98
When, where, why and with whom homeless women engage in risky sexual behaviors: A framework for understanding complex and varied decision-making processes. Sex Roles (2009) 1.96
Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect (2006) 1.92
HIV and AIDS risk behaviors among female jail detainees: implications for public health policy. Am J Public Health (2002) 1.91
The consistency of self-reported HIV risk behavior among injection drug users. Am J Public Health (1994) 1.78
HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health (2000) 1.74
Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse (2003) 1.74
Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev (2003) 1.71
Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health (1991) 1.66
HIV seroprevalence surveys in drug treatment centers. Public Health Rep (1990) 1.59
Cocaine use and stroke. Postgrad Med J (2007) 1.54
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health (1994) 1.52
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health (2009) 1.49
Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ (2001) 1.49
HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest. Am J Public Health (1991) 1.49
A longitudinal study of the prevalence, development, and persistence of HIV/sexually transmitted infection risk behaviors in delinquent youth: implications for health care in the community. Pediatrics (2007) 1.48
HIV seroprevalence among male IVDUs in Houston, Texas. Am J Public Health (1990) 1.47
The association between congenital syphilis and cocaine/crack use in New York City: a case-control study. Am J Public Health (1991) 1.45
HIV risk profile and prostitution among female street youths. J Urban Health (2002) 1.44
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
HIV infection among women entering the New York State correctional system. Am J Public Health (1991) 1.36
Expanding the frame of health services research in the drug abuse field. Health Serv Res (1995) 1.35
Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction (2009) 1.27
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend (2007) 1.26
High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities. Sex Transm Dis (2008) 1.19
Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepat (2008) 1.18
The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study. J Urban Health (2003) 1.16
HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam. Am J Public Health (1992) 1.11
Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med (2011) 1.10
Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care (2011) 1.09
Contingent reinforcement of abstinence with individuals abusing cocaine and marijuana. J Appl Behav Anal (1991) 1.09
Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health (2002) 1.09
Controlling penicillinase-producing Neisseria gonorrhoeae--does it really matter anymore? West J Med (1989) 1.09
The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol (2012) 1.07
The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention. Am J Public Health (1994) 1.07
Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b. PLoS One (2012) 1.03
Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol (2000) 1.00
Heroin and cocaine co-use in a group of injection drug users in Montréal. J Psychiatry Neurosci (2004) 0.98
AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease. Proc Natl Acad Sci U S A (1991) 0.98
The prevalence of high-risk sexual behavior in male intravenous drug users with steady female partners. Am J Public Health (1990) 0.98
Delay and probability discounting of sexual and monetary outcomes in individuals with cocaine use disorders and matched controls. PLoS One (2015) 0.94
Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction. J Neuroimmune Pharmacol (2011) 0.93
Crack Cocaine Injection Practices and HIV Risk: Findings From New York and Bridgeport. J Drug Issues (2004) 0.93
Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms. Curr HIV Res (2012) 0.93
What do we really know about AIDS control? Am J Public Health (1989) 0.92
Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study. CMAJ (1993) 0.91
Marijuana use is associated with risky sexual behaviors in treatment-seeking polysubstance abusers. Am J Drug Alcohol Abuse (2013) 0.90
Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6. Sex Transm Infect (2000) 0.90
Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors. Drug Alcohol Depend (2008) 0.89
Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis. West J Med (1990) 0.88
Reduced probability of HIV infection among crack cocaine--using injection drug users. Am J Public Health (1997) 0.87
Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets. Clin Exp Immunol (1989) 0.87
Demographic characteristics, drug use, and sexual behavior of i.v. drug user with AIDS in Bronx, New York. Public Health Rep (1991) 0.87
Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci (2010) 0.87
Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatients using modified materials. Drug Alcohol Depend (2012) 0.86
Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission. Life Sci (2011) 0.85
AIDS, HIV infection, and illicit drug use within inner-city families and social networks. Am J Public Health (1994) 0.85
Cocaine enhances HIV-1-induced CD4(+) T-cell apoptosis: implications in disease progression in cocaine-abusing HIV-1 patients. Am J Pathol (2014) 0.85
Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications. Thorax (1990) 0.85
Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study. Subst Abuse Treat Prev Policy (2014) 0.85
HIV disease in the intravenous drug user: role of the primary care physician. J Gen Intern Med (1991) 0.84
Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4+ and CD8+ T cells. Clin Exp Immunol (1999) 0.84
Prevalence of HIV Among U.S. Female Sex Workers: Systematic Review and Meta-analysis. AIDS Behav (2016) 0.82
Drug-using male clients of female sex workers who report being paid for sex: HIV/sexually transmitted infection, demographic, and drug use correlates. Sex Transm Dis (2013) 0.81
Rodent models of HAND and drug abuse: exogenous administration of viral protein(s) and cocaine. J Neuroimmune Pharmacol (2012) 0.81
Interactive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDS. Front Microbiol (2015) 0.81
[Injecting without getting infected: injectors' strategies to prevent HIV and HCV.] Trastor Adict (2007) 0.81
Measuring Outcome in the Treatment of Cocaine Dependence. J Alcohol Drug Depend (2013) 0.81
SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation. J Neuroimmune Pharmacol (2011) 0.80
Cocaine modulates HIV-1 integration in primary CD4+ T cells: implications in HIV-1 pathogenesis in drug-abusing patients. J Leukoc Biol (2015) 0.79
Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding. J Neuroimmune Pharmacol (2015) 0.79
Primary care for AIDS and chemical dependence. West J Med (1990) 0.79
Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients. J Subst Abuse Treat (2004) 0.78
Pharmacologic approaches to the treatment of cocaine dependence. West J Med (1990) 0.77
Impact of cocaine abuse on HIV pathogenesis. Front Microbiol (2015) 0.76
Role of Autophagy in HIV Pathogenesis and Drug Abuse. Mol Neurobiol (2016) 0.75
Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk. Drug Alcohol Rev (2015) 0.75
Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation. Front Microbiol (2016) 0.75
A success story--waiting to be retold: methadone treatment in New York City. Bull N Y Acad Med (1993) 0.75
Intravenous cocaine and HIV infection. JAMA (1989) 0.75
Counseling patients seropositive for human immunodeficiency virus. An approach for medical practice. West J Med (1990) 0.75
A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addict Res Theory (2016) 0.75
Cocaine hydrochloride and benzoylecgonine have no in vitro inhibitory effect against Neisseria gonorrhoeae. Antimicrob Agents Chemother (1991) 0.75
AIDS-related behavioral research and nursing. J Natl Med Assoc (1991) 0.75
Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11
Preventable hospitalizations and access to health care. JAMA (1995) 11.49
Primary care physicians' experience of financial incentives in managed-care systems. N Engl J Med (1998) 9.31
Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA (1997) 8.24
Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA (1998) 8.02
Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med (1992) 6.30
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med (1989) 6.29
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
The continuing HIV epidemic among men who have sex with men. Am J Public Health (2001) 5.56
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet (2001) 5.28
Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother (1974) 5.19
HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health (1994) 5.18
Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health (1987) 5.06
Sexual harassment in medical training. N Engl J Med (1993) 4.93
Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis (1979) 4.70
The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med (1995) 4.60
Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest (1978) 4.38
Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med (1975) 4.23
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) (1988) 4.03
HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA (1994) 3.80
Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med (2001) 3.75
Natural history of HIV infection. AIDS (1989) 3.75
HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS (1994) 3.67
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis (1975) 3.52
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
Primary care and receipt of preventive services. J Gen Intern Med (1996) 3.26
A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med (1999) 3.26
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med (2001) 3.15
Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med (1980) 3.03
Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis (2001) 2.87
Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. J Infect Dis (1984) 2.77
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J Infect Dis (1974) 2.64
Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol (1987) 2.62
Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med (1989) 2.58
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
Protease inhibitors in the homeless. JAMA (1997) 2.57
Use of T lymphocyte subset analysis in the case definition for AIDS. J Acquir Immune Defic Syndr (1993) 2.57
Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology (2001) 2.54
Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med (1982) 2.52
Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons. Am J Respir Crit Care Med (1998) 2.52
Projections of AIDS morbidity and mortality in San Francisco. JAMA (1990) 2.42
Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37
Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA (1998) 2.36
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis (1987) 2.32
Incubation period of AIDS in San Francisco. Nature (1989) 2.26
The impact of HIV on chronic kidney disease outcomes. Kidney Int (2007) 2.22
Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet (1989) 2.18
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med (2001) 2.17
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis (1985) 2.10
AIDS and intravenous drug use: the real heterosexual epidemic. Br Med J (Clin Res Ed) (1987) 2.08
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
The HIV epidemic and training in internal medicine. Challenges and recommendations. N Engl J Med (1989) 2.06
Uncomplicated acute bronchitis. Ann Intern Med (2000) 2.06
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis (1975) 2.05
A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Am J Med (1998) 2.04
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03
Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis (1984) 2.00
Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol (1986) 1.97
Methods to improve detection of pneumococci in respiratory secretions. J Clin Microbiol (1975) 1.94
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest (1983) 1.93
Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med (1996) 1.92
Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. J Infect Dis (1988) 1.90
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med (2001) 1.89
Role of the vegetation in experimental Streptococcus viridans endocarditis. Infect Immun (1974) 1.89
In vitro susceptibility studies with josamycin and erythromycin. Antimicrob Agents Chemother (1976) 1.89
Multiple use of disposable insulin syringe-needle units. JAMA (1980) 1.89
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis (1975) 1.88
Routine use of anaerobic blood cultures: are they still indicated? Am J Med (2000) 1.88
Comparative pharmacology of cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.86
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1985) 1.85
Overdosing among young injection drug users in San Francisco. Addict Behav (2001) 1.84
Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium. N Engl J Med (1979) 1.84
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 1.75
Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1975) 1.75
Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med (1976) 1.73
Prehospital stability of diazepam and lorazepam. Am J Emerg Med (1999) 1.72
Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun (1983) 1.72
Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.70
Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med (1993) 1.70
Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence. Clin Immunol Immunopathol (1986) 1.68
Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits. J Infect Dis (1978) 1.68
Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis (1990) 1.67
The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis (1984) 1.67
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis (1985) 1.66
Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun (1978) 1.66